22 May 2013
Keywords: novo, nordisk, levemir, track, eu, european, union
Article | 08 March 2004
The European Union's Committee for Proprietary Medicinal Products has given a positive opinion for the use of Novo Nordisk's Levemir ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.